Fed Spend Map

The Institute for Cancer ResearchFederal contracts and grants

  • Philadelphia, PA
  • UEI FF1XVJMDYVR1

USAspending shows $120M in obligations to this recipient in 4 of the 5 fiscal years from FY2023 to FY2027.

The obligations in FY2026 were $28M.

The obligations in FY2027 to date are under $1 million.

The awards of $1 million or more that started since FY2023 came from 2 agencies.

The largest award value came from the Department of Health and Human Services.

A fiscal year under $1 million is not in the total.

Places of performanceAward value since FY2023

The states where the work of the awards of $1 million or more is done. The swatches go from the smallest award value to the largest. The largest is Pennsylvania: $51M.

Pennsylvania: the address of the recipient.

The amounts for each state. Outlines: US Census Bureau.

An outlay occurs when federal money is actually paid out, not just promised to be paid ("obligated").

Procurement data (such as for contracts and indefinite delivery vehicles (IDV)) for the Department of Defense (DOD) and U.S. Army Corps of Engineers (USACE) are published on a 90-day delay in the Federal Procurement Data System (FPDS).

Maintaining data quality for the award description field has been persistently challenging for federal agencies.

These are the words of USAspending. Sources: USAspending.gov, About the Data (PDF, last updated 19 November 2025) and USAspending.gov, Glossary. The site copied them on .

The amounts on this page are obligations. An obligation is a promise to pay. It is not a payment. Contract records of the Department of Defense come late, so a recent month can be low. The text under a name in a list of awards is the description that the agency wrote.

USAspending loaded the data on . USAspending profile of this recipient

Since the last update

No change is on record for this page.

The site compares each data load with the load before it. It records a change of the FY2027 obligations when the change is $1 million or more and 10% or more. It also records each new award of $1 million or more.

Obligations by fiscal year

Obligations to The Institute for Cancer Research by fiscal yearA fiscal year starts on 1 October. "Under $1 million" is a year below the listing floor: the amount is not zero, and the site does not list it. FY2027 runs from 1 October 2026 to 30 September 2027. USAspending loaded these data on 30 Sep 2026, so the figures of FY2027 stop on that date.
Fiscal yearAll obligationsContractsOther awards
FY2023$31M$2.2M$29M
FY2024$28M$1.7M$26M
FY2025$33Munder $1 million$33M
FY2026$28Munder $1 million$28M
FY2027 to dateunder $1 million

Contracts are the procurement award types. Other awards are grants, direct payments, loans (subsidy cost) and other assistance. The contracts figure shows only when contracts alone are $1 million or more.

Awarding agencies

Health and Human Services $45MDefense $6.2MContracts$2.2MGrants$49M
Award value from each agency to each award type, for awards of $1 million or more that started in FY2023 or later. The solid bands are contracts, the hatched bands are grants and the open bands are other assistance. The table gives the amounts.
Agencies that gave awards of $1 million or more to The Institute for Cancer ResearchAwards that started in FY2023 or later, by award value, largest first.
AgencyAwardsAward valueShare
Department of Health and Human Services23$45M88%
Department of Defense4$6.2M12%

Awards

The newest awards of $1 million or more to The Institute for Cancer ResearchNewest first. The text under the agency is the description on USAspending.
Awarding agencyTypeIndustry or programAward valueStart datePlaceRecord
Department of Health and Human ServicesNational Institutes of HealthGrantCooperative Agreement (B)93.172 Human Genome Research$1.4M26 Aug 2025PAUSAspending
Department of DefenseDefense Health AgencyGrantProject Grant (B)12.420 Military Medical Research and Development$2.0M25 Jul 2025PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthGrantProject Grant (B)93.396 Cancer Biology Research$1.3M7 Mar 2025PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthGrantProject Grant (B)93.859 Biomedical Research and Research Training$1.4M13 Sep 2024PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthGrantProject Grant (B)93.396 Cancer Biology Research$1.9M31 Jul 2024PAUSAspending
Awards of $1 million or more to The Institute for Cancer Research that started in FY2023 or laterBy award value, largest first. The award value is the amount obligated to the award to date. The site does not show a description that has the name of a person.
Awarding agencyTypeIndustry or programAward valueStart datePlaceRecord
Department of Health and Human ServicesNational Institutes of HealthROLE OF ZBP1 IN PATHOGENESIS OF SALMONELLA BIOFILMS - PROJECT SUMMARY INFECTIONS WITH ENTERIC PATHOGENS SUCH AS SALMONELLA, CAMPYLOBACTER, SHIGELLA, OR ...GrantProject Grant (B)93.855 Allergy and Infectious Diseases Research$3.4M11 May 2023PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthSMALL-MOLECULE EXPLOITATION OF ZBP1-DRIVEN NUCLEAR NECROPTOSIS FOR CANCER IMMUNOTHERAPY - PROJECT SUMMARY/ABSTRACT. IMMUNE CHECKPOINT BLOCKADE (ICB) AND OTHER ...GrantProject Grant (B)93.395 Cancer Treatment Research$3.0M16 Dec 2022PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthTARGETING THE BCL2 IMMUNE CHECKPOINT TO ENHANCE THE IMMUNOSTIMULATORY EFFECTS OF RADIATION IN BREAST CANCER - SUMMARY HORMONE RECEPTOR (HR)+ BREAST CANCER (BC) ...GrantProject Grant (B)93.395 Cancer Treatment Research$2.9M1 Aug 2023PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthDIVERGENT FUNCTIONS OF ERK SUBSTRATE BINDING DOMAINS IN PATHOGENESIS OF MYELOPROLIFERATIVE NEOPLASMS - PROJECT SUMMARY/ABSTRACT THE RAS/MAPK PATHWAY IS ...GrantProject Grant (B)93.396 Cancer Biology Research$2.8M6 Jul 2023PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthREDUCING URBAN CERVICAL CANCER DISPARITIES USING A TAILORED MHEALTH INTERVENTION TO ENHANCE COLPOSCOPY ATTENDANCE - PROJECT SUMMARY/ABSTRACT CERVICAL CANCER IS ...GrantProject Grant (B)93.307 Minority Health and Health Disparities Research$2.8M4 Jun 2023PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthNEIGHBORHOOD, SOCIAL CONNECTEDNESS, AND ALLOSTATIC LOAD IN US CHINESE IMMIGRANTS - PROJECT SUMMARY ASIAN AMERICANS ARE THE FASTEST-GROWING RACIAL/ETHNIC GROUP ...GrantProject Grant (B)93.307 Minority Health and Health Disparities Research$2.6M16 May 2023PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthEXAMINING THE RELATIONSHIP BETWEEN RESIDENTIAL HISTORY AT MIDLIFE AND PROSTATE CANCER OUTCOMES - ABSTRACT PROSTATE CANCER (PCA) IS ONE OF A FEW CANCERS WITH ...GrantProject Grant (B)93.307 Minority Health and Health Disparities Research$2.6M16 Aug 2023PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthPROMOTING EFFECTIVE CLINICAL COMMUNICATION ABOUT SEXUAL HEALTH AFTER GYNECOLOGIC CANCER: A RANDOMIZED CONTROLLED TRIAL OF A PATIENT-FOCUSED INTERVENTION - ...GrantProject Grant (B)93.395 Cancer Treatment Research$2.5M1 Jul 2024PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthTELOMERASE RNP PRISONBREAKS FROM PHASE-SEPARATED NUCLEAR BODY - PROJECT SUMMARY OVERVIEW: THE RIBONUCLEOPROTEIN ENZYME TELOMERASE MAINTAINS TELOMERE LENGTH ...GrantProject Grant (B)93.859 Biomedical Research and Research Training$2.1M29 Jun 2023PAUSAspending
Department of DefenseDefense Health AgencyPEMBROLIZUMAB MAINTENANCE AFTER ENFORTUMAB VEDOTIN/PEMBROLIZUMAB INDUCTION IN FRONT-LINE METASTATIC UROTHELIAL CARCINOMA.GrantProject Grant (B)12.420 Military Medical Research and Development$2.0M25 Jul 2025PAUSAspending
Department of Health and Human ServicesNational Institutes of HealthTARGETING DHX9 TO TRIGGER VIRAL MIMICRY AND IMMUNOTHERAPY RESPONSIVENESS IN SMALL CELL LUNG CANCER (SCLC) - PROJECT SUMMARY / ABSTRACT DESPITE THE IMPRESSIVE ...GrantProject Grant (B)93.396 Cancer Biology Research$1.9M31 Jul 2024PAUSAspending
Department of DefenseDefense Health AgencyTARGETING THE SRPK1-AKT SIGNALING AXIS IN ENDOMETRIAL CANCERGrantProject Grant (B)12.420 Military Medical Research and Development$1.9M4 Aug 2023PAUSAspending

Industries, programs and places of performance

Contract industries (NAICS)Award value of the awards of $1 million or more, largest first.
IndustryAwardsAward value
541714 Research and Development in Biotechnology (except Nanobiotechnology)2$2.2M
States of the place of performanceAward value of the awards of $1 million or more, largest first. The place of performance is where the work is done.
StateAwardsAward value
Pennsylvania27$51M

The counties with the largest award value, largest first.

Other recipients of about the same size

Recipients in the same NAICS sector, with an address in Pennsylvania. In order of name. These recipients have obligations nearest to those of The Institute for Cancer Research in the listed fiscal years.

All recipients in Pennsylvania, in order of name.

Official records

Each link opens a page of a federal agency in a new tab. The site examined the links on .

Cite this page

Fed Spend Map. "The Institute for Cancer Research: federal contracts and grants". Data: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, loaded .

https://fedspendmap.com/recipient/ff1xvjmdyvr1-the-institute-for-cancer-research/

The address of this page is permanent.

Where the figures come from

USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service). Fiscal year obligations: the list of recipients by state, with a listing floor of $1 million for each year. Awards: the award search, new awards of $1 million or more by base obligation date. Parent and business types: the recipient profile.

USAspending loaded the data on 30 Sep 2026. A closed fiscal year is a copy made after the year end. The site shows organisations only. The site corrects an error in its own work at the next build. See how to report an error and how the atlas is made.

Questions

Which fiscal years are in the total?

The total has 4 fiscal years.

  • FY2023: $31M
  • FY2024: $28M
  • FY2025: $33M
  • FY2026: $28M
  • FY2027 to date: under $1 million

The site lists a fiscal year of a recipient when the obligations of the year are $1 million or more.

Which industries and programs do the awards name?

The contract awards of $1 million or more name 1 NAICS industry.

The largest award value is in NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology): $2.2M.

The assistance awards name 6 assistance listings.

The largest award value is in listing 93.395, Cancer Treatment Research: $13M.

Where is the place of performance?

The awards of $1 million or more name 1 state as the place of performance.

The largest award value is in Pennsylvania: $51M.

The place of performance is where the work is done. It is not always the address of the recipient.

How many awards are in the lists on this page?

The lists hold 27 awards of $1 million or more that started in FY2023 or later.

Their award value is $51M.

An award under that amount is in the obligations of the fiscal years but not in the lists.